--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and ...

The ranibizumab injection delivered through an implant device could be administered in a convenient schedule twice per year ...

They also will evaluate advances in imaging and current and emerging therapies for the treatment and management of retinal vein occlusion. Upon successful completion of this educational activity ...

The EYLEA HD results were consistent across patients with branch retinal vein occlusions ... of EYLEA HD in its pivotal trials. Ocular treatment-emergent adverse events (TEAEs) occurring in ...

A variety of retinal signs can occur in patients who have systemic vasculitides, or who experience complications of these diseases or their treatment. Although treatment of these retinal ...

The two most important factors in the development of rhegmatogenous retinal detachment are retinal breaks and vitreous traction. The two goals of retinal reattachment surgery are to seal all ...

Gallup characterizes this trend as the "Great Detachment." While employees may still be physically present, many are psychologically distant. This disengagement can often be subtle, requiring ...

The continued evolution of treatment protocols and imaging modalities for the management of retinal diseases offer the potential to further optimize visual and anatomical outcomes for patients ...

In their last study, IIT's research group saw for the first time that Ziapin2 also acts in a similar manner on neurons in the inner retina unaffected by degeneration, particularly at the bipolar ...